Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas

SIMPLE SUMMARY: Soft tissue sarcomas (STSs) are rare and highly heterogeneous tumors that are difficult to treat. Gemcitabine plus docetaxel is an effective treatment for advanced STS. However, the prognosis for patients remains poor, and thus there is an urgent medical need for novel and effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Attia, Steven, Villalobos, Victor, Hindi, Nadia, Wagner, Andrew J., Chmielowski, Bartosz, Oakley, Gerard J., Peterson, Patrick M., Ceccarelli, Matteo, Jones, Robin L., Dickson, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572019/
https://www.ncbi.nlm.nih.gov/pubmed/37835565
http://dx.doi.org/10.3390/cancers15194871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572019/
https://www.ncbi.nlm.nih.gov/pubmed/37835565
http://dx.doi.org/10.3390/cancers15194871

Ejemplares similares